Published in Immunology on November 01, 1999
Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity (2008) 3.33
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology (2011) 2.03
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol (2002) 1.44
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med (2005) 1.43
Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis (2004) 1.39
Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol (2008) 1.32
Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res (2001) 1.26
Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 1.26
Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease. Front Immunol (2013) 1.20
Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology (2001) 1.18
Proliferation and interleukin 5 production by CD8hi CD57+ T cells. Eur J Immunol (2008) 1.16
Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci (Landmark Ed) (2009) 1.03
Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology (2010) 0.97
Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome. Clin Exp Immunol (2004) 0.95
Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses. Immun Ageing (2006) 0.94
Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clin Exp Immunol (2001) 0.93
The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology (2001) 0.92
Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol (2004) 0.91
Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes. J Am Soc Nephrol (2008) 0.88
In vivo and in vitro techniques for comparative study of antiviral T-cell responses in the amphibian Xenopus. Biol Proced Online (2008) 0.87
Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy. Immunology (2006) 0.83
Ex vivo analysis of phenotype and TCR usage in relation to CD45 isoform expression on cytomegalovirus-specific CD8+ T lymphocytes. Clin Exp Immunol (2001) 0.83
Antigen-independent acquisition of MHC class II molecules by human T lymphocytes. Int Immunol (2004) 0.83
Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediators Inflamm (2004) 0.81
CD28⁻ CD8⁺ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes. Hum Immunol (2014) 0.79
CD57 expression by T cells in the female genital tract of HIV-zx1 infected women. Clin Immunol (2010) 0.79
Impact of cytomegalovirus and grafts versus host disease on the dynamics of CD57+CD28-CD8+ T cells after bone marrow transplant. Clinics (Sao Paulo) (2008) 0.77
Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection. World J Virol (2015) 0.75
Tracking TCRβ Sequence Clonotype Expansions during Antiviral Therapy Using High-Throughput Sequencing of the Hypervariable Region. Front Immunol (2016) 0.75
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
The B7 and CD28 receptor families. Immunol Today (1994) 6.38
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol (1996) 4.45
Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med (1994) 4.41
CD28- T lymphocytes. Antigenic and functional properties. J Immunol (1993) 3.67
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med (1982) 2.35
Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol (1994) 2.00
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93
CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol (1995) 1.92
Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol (1986) 1.83
Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J Immunol (1999) 1.71
The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol (1999) 1.67
Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol (1999) 1.50
CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses. Eur J Immunol (1994) 1.49
Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. J Immunol (1995) 1.47
Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Clin Exp Immunol (1995) 1.40
Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol (1993) 1.38
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis (1984) 1.37
Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometry. Immunol Rev (1983) 1.27
Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J Infect Dis (1985) 1.21
Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS). J Clin Immunol (1987) 1.08
CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol (1994) 1.08
Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals. J Clin Immunol (1986) 1.05
The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood. Immunology (1986) 1.04
Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status. Clin Exp Immunol (1988) 1.03
Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection. Eur J Immunol (1998) 0.87
Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb. J Immunol (1993) 0.84
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol (1996) 4.45
Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol (2000) 3.18
Phytic acid and nutritional rickets in immigrants. Lancet (1972) 3.17
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
Muscle weakness in osteomalacia. Lancet (1976) 2.42
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur J Immunol (1983) 2.34
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol (1994) 2.31
Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet (1974) 2.19
Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur J Immunol (1988) 2.13
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Direct comparison of corticospinal volleys in human subjects to transcranial magnetic and electrical stimulation. J Physiol (1993) 2.05
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
One-day fluorescent-antibody procedure for detecting salmonellae in frozen and dried foods. Appl Microbiol (1970) 1.90
Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol (1993) 1.82
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet (1983) 1.73
On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. Proc Natl Acad Sci U S A (1986) 1.72
Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J Immunol (1999) 1.71
The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol (1999) 1.67
Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J Virol (1991) 1.62
Immunofluorescent staining of Salmonella species with flagellar sera. Appl Microbiol (1969) 1.61
Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J Gen Virol (1992) 1.57
Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab (1968) 1.55
Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53
Gait patterns in spastic hemiplegia in children and young adults. J Bone Joint Surg Am (1987) 1.51
Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol (1999) 1.50
Extramammary Paget's disease of the axilla with an underlying apocrine carcinoma. Acta Derm Venereol (1996) 1.48
Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc Natl Acad Sci U S A (1980) 1.48
The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol (1978) 1.47
Pathological missense mutations of neural cell adhesion molecule L1 affect homophilic and heterophilic binding activities. EMBO J (1999) 1.47
Simulated bone metastases: a case study of two patients with breast cancer. Australas Radiol (1999) 1.45
The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res (1994) 1.44
Normocalcaemic primary hyperparathyroidism. Lancet (1971) 1.42
Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res (1989) 1.40
Fluphenazine enanthate in the maintenance treatment of Schizophrenia. Br Med J (1966) 1.38
Fixed drug eruption with fluconazole. BMJ (1994) 1.36
Antibody-mediated destruction of virus-infected cells. Adv Immunol (1980) 1.34
Transferrin binding of Al3+ and Fe3+. Clin Chem (1987) 1.34
Hypercalcemia associated with chronic lymphocytic leukemia. Arch Intern Med (1979) 1.33
Seasonal variation in serum-25-hydroxyvitamin-D in the elderly in Britain. Lancet (1977) 1.32
Apparent change in the pK' 1 of carbonic acid in plasma in response to acute metabolic acidosis in normal subjects. Clin Chim Acta (1971) 1.30
Normocalcemic primary hyperparathyroidism. Am J Med (1969) 1.30
Observations on the pharmacological properties of inflammatory exudate. Eur J Pharmacol (1969) 1.29
Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet (1976) 1.27
Ultramicrofluorimetric determination of calcium in plasma. J Clin Pathol (1969) 1.27
Latency and reactivation of human cytomegalovirus. J Infect (2002) 1.26
Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol (1993) 1.26
Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus. J Virol (1985) 1.25
The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res (1991) 1.23
The pathophysiology of congenital chloridorrhoea. Q J Med (1973) 1.21
Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol (2001) 1.21
Isolated glomerulonephritis with mesangial IgA deposits. Br Med J (1975) 1.20
Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol (1987) 1.20
Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut (1978) 1.19
Effect of volatile fatty acids on Salmonella typhimurium. J Bacteriol (1969) 1.19
An epidemic of Kawasaki syndrome in Hawaii. J Pediatr (1982) 1.19
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.18
Transcranial electrical stimulation of the motor cortex in man: further evidence for the site of activation. J Physiol (1994) 1.17
Novel management of harlequin syndrome with stellate ganglion block. Br J Dermatol (2013) 1.17
Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice. J Gen Virol (1995) 1.13
Mortality of the surgical treatment of diverticulitis. Am J Surg (1971) 1.13
In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon. J Exp Med (1981) 1.13
Plasma "cortisol" response to Synacthen in patients on long-term small-dose prednisone therapy. Ann Rheum Dis (1968) 1.12
Cytotoxic T cells and human herpes virus infections. Curr Top Microbiol Immunol (1994) 1.12
Intravenous etidronate in the management of malignant hypercalcemia. Arch Intern Med (1985) 1.12
Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol (1994) 1.11
Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int (1993) 1.11
Gas chromatographic quantitation of two plasticizers contaminating intravenous fluids stored in plastic containers. J Chromatogr (1981) 1.10
Human cytomegalovirus and monocytes: limited infection and negligible immunosuppression in normal mononuclear cells infected in vitro with mycoplasma-free virus strains. J Gen Virol (1989) 1.09
Clinical signs and symptoms in pulp disease. Int Endod J (1980) 1.08
Is there a relationship between systemic perfusion temperature during coronary artery bypass grafting and extent of intraoperative ischemic central nervous system injury? J Thorac Cardiovasc Surg (2000) 1.08
Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia. Lancet (1977) 1.08
Complement activation in asymptomatic patients with sickle cell anaemia. Clin Exp Immunol (1979) 1.07
Critical appraisal of two methods for determining aluminum in blood samples. Clin Chem (1990) 1.06
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. Clin Microbiol Infect (2009) 1.05
Expression of oncogenic ras in human teratocarcinoma cells induces partial differentiation and permissiveness for human cytomegalovirus infection. J Gen Virol (1989) 1.05
Corticosteroid modification of guinea-pig anaphylaxis. J Pharm Pharmacol (1969) 1.05
Clinical aspects and management of cytomegalovirus infection. J Infect (2002) 1.05
Frequency of hypomagnesemia in hypokalemic states. Clin Chem (1983) 1.04
Self-induced glomerulonephritis. Br Med J (1974) 1.04
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
Plasma hydroxyproline in renal osteodystrophy. Proc Eur Dial Transplant Assoc (1973) 1.04
Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. Lancet (1976) 1.03
Observations on plasma magnesium levels in patients with uremic neuropathy under treatment by periodic hemodialysis. Neurology (1970) 1.03
Factors determining the development of anaphylactic hypersensitivity in the guinea pig, and their influence on mechanisms involved in desensitization. Int Arch Allergy Appl Immunol (1968) 1.02